These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16797966)

  • 1. Active immunotherapy of multiple myeloma.
    Houet L; Veelken H
    Eur J Cancer; 2006 Jul; 42(11):1653-60. PubMed ID: 16797966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignancies.
    Leitch HA; Connors JM
    Curr Opin Investig Drugs; 2005 Jun; 6(6):597-604. PubMed ID: 15988911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunotherapy for multiple myeloma.
    Rosenblatt J; Avigan D
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):559-77. PubMed ID: 18790455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma.
    Neelapu SS; Munshi NC; Jagannath S; Watson TM; Pennington R; Reynolds C; Barlogie B; Kwak LW
    Bone Marrow Transplant; 2005 Aug; 36(4):315-23. PubMed ID: 15968284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in multiple myeloma: current strategies and future prospects.
    Yi Q
    Expert Rev Vaccines; 2003 Jun; 2(3):391-8. PubMed ID: 12903804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapeutic strategies for the treatment of plasma cell malignancies.
    Treon SP; Raje N; Anderson KC
    Semin Oncol; 2000 Oct; 27(5):598-613. PubMed ID: 11049026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-based immunotherapy for multiple myeloma: current approaches.
    Zhou FL; Meng S; Zhang WG; Wei YC; Cao XM; Bai GG; Wang BY
    Vaccine; 2010 Aug; 28(37):5939-46. PubMed ID: 20619381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research.
    Bogen B; Ruffini PA; Corthay A; Fredriksen AB; Frøyland M; Lundin K; Røsjø E; Thompson K; Massaia M
    Haematologica; 2006 Jul; 91(7):941-8. PubMed ID: 16818282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma.
    Gorschlüter M; Ziske C; Glasmacher A; Schmidt-Wolf IG
    Clin Cancer Res; 2001 Aug; 7(8):2195-204. PubMed ID: 11489792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells.
    Rasmussen T; Hansson L; Osterborg A; Johnsen HE; Mellstedt H
    Blood; 2003 Jun; 101(11):4607-10. PubMed ID: 12576327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current role of immunotherapy in multiple myeloma.
    Hájek R; Adam Z; Krivanová A; Doubek M; Korístek Z; Vorlícek J
    Acta Med Austriaca; 1998; 25(3):79-85. PubMed ID: 9816399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine therapy for renal cancer.
    Amato RJ
    Expert Rev Vaccines; 2008 Sep; 7(7):925-35. PubMed ID: 18767943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic lymphoma vaccines: importance of T-cell immunity.
    Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
    Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in multiple myeloma--possibility or probability?
    Harrison SJ; Cook G
    Br J Haematol; 2005 Aug; 130(3):344-62. PubMed ID: 16042684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells in myeloma.
    Raitakari M; Brown RD; Gibson J; Joshua DE
    Hematol Oncol; 2003 Mar; 21(1):33-42. PubMed ID: 12605421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines.
    Raez LE; Santos ES; Mudad R; Podack ER
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):635-44. PubMed ID: 16111464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.
    Rhee Fv
    Clin Cancer Res; 2007 Mar; 13(5):1353-5. PubMed ID: 17332275
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma.
    Vari F; Munster DJ; Hsu JL; Rossetti TR; Mahler SM; Gray PP; Turtle CJ; Prue RL; Hart DN
    Br J Haematol; 2008 Nov; 143(3):374-7. PubMed ID: 18729856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific T-cell immunity in multiple myeloma patients is restored following high-dose therapy: implications for timing of vaccination.
    Svane IM; Nikolajsen K; Johnsen HE
    Scand J Immunol; 2007 Oct; 66(4):465-75. PubMed ID: 17850592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.